Adenovirus Packaging Services
Inquiry
Adenoviral vectors offer unique advantages in oncology research scenarios requiring rapid, high-level transgene expression, including oncogene functional validation, apoptosis induction assessment, and immunostimulatory molecule delivery. As a preclinical CRO specialized in the oncology field, Alfa Cytology provides high-quality adenovirus packaging services designed to deliver efficient and transient gene delivery tools for your research projects. Leveraging our well-established adenovirus production platform and rigorous quality control systems, our experienced scientists are committed to producing high-titer, high-purity adenoviral vectors tailored to meet your specific research needs.
Introduction to Adenovirus Packaging
Adenovirus is a non-enveloped, double-stranded DNA virus widely used in cancer research and gene therapy due to its high transduction efficiency, broad host range, and non-integrating nature. The virus enters cells via fiber protein–receptor (e.g., CAR) binding and receptor-mediated endocytosis, with its genome remaining episomal in the nucleus, enabling robust transient transgene expression without insertional mutagenesis risk. Adenoviral vectors accommodate large inserts (8–10 kb) and are readily propagated to high titers in HEK293 cells and derivatives. Most current systems are E1/E3-deleted, replication-defective Ad5-based vectors with reduced immunogenicity and cytotoxicity. Optimized MOI, harvest timing, and purification methods (e.g., CsCl gradients or chromatography) yield highly active, low-impurity preparations. In oncology, these vectors are broadly applied in transient overexpression, pathway analysis, recombinant protein production, and tumor vaccine development, being particularly advantageous for scenarios requiring rapid, high-level gene expression, such as oncogene validation, apoptosis assessment, and transient delivery of immunostimulatory molecules.
Fig. 1 Process development for high-titer production of adenovirus devoid of replication-competent particles in suspension-adapted complementing A549 cell culture. (Shen CF, et al.; 2025)
Our Services
Leveraging our advanced adenovirus production platform and stringent quality control systems, Alfa Cytology provides high-quality adenovirus packaging services for researchers in oncology and related fields. Our comprehensive service offerings cover the entire workflow—from vector design, virus packaging, and purification/concentration, to full-spectrum quality control. We support three purification grades to flexibly accommodate diverse application needs, ranging from in vitro mechanistic studies to in vivo efficacy evaluation and vaccine development.
Vector Design and Construction
Based on your research objectives, we design and construct adenoviral vectors carrying your gene of interest or other genetic elements. Our services include:
- PCR amplification and cloning of the gene of interest.
- Homologous recombination between shuttle vector and backbone vector.
- Codon optimization (if required).
- Incorporation of fusion tags and reporter genes.
- Full-length sequencing verification to ensure 100% accuracy of the inserted sequence.
Virus Packaging and Production
We employ optimized production processes for adenovirus packaging:
- Transfection of linearized plasmid into HEK293 cells.
- Intracellular homologous recombination to generate recombinant adenoviral genomes.
- Multiple rounds of amplification to achieve high-titer virus stocks.
- Serum-free culture system to avoid exogenous factor contamination.
Virus Purification and Concentration
We offer different levels of purification protocols tailored to your application requirements:
- Standard purification: Virus harvest via cell lysis and PEG precipitation.
- High-purity purification: CsCl density gradient centrifugation or ion-exchange chromatography to effectively remove cellular proteins and nucleic acid residues.
- Ultra-pure purification: Suitable for in vivo injection and vaccine research applications.
Quality Control Testing
Each batch of adenovirus undergoes comprehensive quality control testing:
- Titer determination: Infectious titer (PFU/mL) measured by TCID50 or plaque assay; physical titer measured by qPCR.
- Purity assessment: SDS-PAGE analysis and A260/A280 ratio determination.
- Replication competence testing: Detection of replication-competent adenovirus (RCA) content.
- Sterility testing: Bacterial, fungal, and mycoplasma detection.
- Activity validation: Verification of transgene expression in target cells.
Specifications
| Parameter |
Specification |
| Vector System |
Adenovirus serotype 5 (Ad5) with E1/E3 deletion |
| Packaging Cell Line |
HEK293 / HEK293A |
| Recombination Method |
Homologous recombination (AdEasy system or equivalent) |
| Titer Range |
1010–1011 PFU/mL |
| Packaging Capacity |
8–10 kb |
| Virus Volume |
Customizable according to requirements (200 μL–5 mL) |
| Purification Grade |
Standard grade / High-purity grade / Ultra-pure grade |
| Quality Control Standards |
TCID50 / plaque assay titer, RCA testing, sterility testing |
Applications of Adenoviral Vectors in Cancer Research
Transient Protein Overexpression
Adenoviral infection achieves high-level transient expression of target genes in host cells, suitable for protein function studies, protein-protein interaction analysis, and recombinant protein production.
Signaling Pathway Modulation
Constitutively active or dominant-negative mutants are delivered via adenovirus to specifically activate or inhibit key nodes in signaling pathways, enabling dissection of upstream activation mechanisms and downstream effector networks.
Transient Gene Function Studies
Adenovirus enables rapid and reversible assessment of gene function without permanent genomic alterations, making it suitable for short-term functional screening in primary cells and stem cells.
Tumor Vaccine Development
Adenovirus serves as a vaccine vector for efficient delivery of tumor-associated antigens or neoantigens, activating specific antitumor T-cell immune responses to support early-stage therapeutic vaccine development.
Recombinant Protein Production
Leveraging the high-efficiency protein expression capacity of adenovirus, recombinant proteins and virus-like particles can be rapidly produced in mammalian cells for antigen preparation, antibody screening, and structural biology studies.
Conditional Gene Expression
In combination with the Cre-LoxP system, adenovirus enables conditional gene regulation in specific cell or tissue types, supporting cell lineage tracing and spatially restricted gene function studies.
Service Highlights
- High titer: Achieves up to 1010–1011 PFU/mL, ensuring high-efficiency infection.
- Large packaging capacity: Supports insertion of exogenous genes up to 8–10 kb.
- Transient expression: Non-integrating into the host genome, ideal for gene function studies with well-defined time windows.
- Multiple purification grades: Offers Standard, High-purity, and Ultra-pure grades to meet diverse application requirements.
- Strict quality control: Each batch is subjected to titer determination, RCA testing, and sterility testing.
- Rapid turnaround: Streamlined workflow to accelerate your research progress.
Alfa Cytology integrates an advanced adenovirus production platform with rigorous project management and exceptional scientific expertise. Whether your research involves transient overexpression studies, signaling pathway analysis, or vaccine development, we are your trusted partner in accelerating cancer research. Please do not hesitate to contact us to discuss your project and learn how Alfa Cytology can support your drug discovery journey.
References
- Charman M, et al. Mysteries of adenovirus packaging. Journal of Virology. 2025;99(5):e0018025.
- Shen CF, et al. Process development for high-titer production of adenovirus devoid of replication-competent particles in suspension-adapted complementing A549 cell culture. BMC Biotechnol. 2025;25(1):119.
For research use only.
Related Services
